Observational studyThe Permanente journal2021
Description and Early Results of the Kaiser Permanente Southern California COVID-19 Home Monitoring Program.
Observational study in The Permanente journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 30 citations in OpenAlex.
- Pulse Oximetry for Monitoring Patients with Covid-19 at Home - A Pragmatic, Randomized Trial.The New England journal of medicine · 2022Trial
- Integrated health systems and medical care quality during the COVID-19 pandemic.Health services research · 2025Article
- Review
- Managing Patients With COVID-19 in Armenia Using a Remote Monitoring System: Descriptive Study.JMIR public health and surveillance · 2024Article
- Large-scale Implementation of a COVID-19 Remote Patient Monitoring Program.The western journal of emergency medicine · 2023Observational
- Remote patient monitoring for COVID-19 patients: comparisons and framework for reporting.BMC health services research · 2023Review
- Increased vaccine sensitivity of an emerging SARS-CoV-2 variant.Nature communications · 2023Article
- Patient and clinician perspectives of a remote monitoring program for COVID-19 and lessons for future programs.BMC health services research · 2023Article
- Unraveling the Underlying Molecular Mechanism of 'Silent Hypoxia' in COVID-19 Patients Suggests a Central Role for Angiotensin II Modulation of the AT1R-Hypoxia-Inducible Factor Signaling Pathway.Journal of clinical medicine · 2023Review
- Association of SARS-CoV-2 BA.4/BA.5 Omicron lineages with immune escape and clinical outcome.Nature communications · 2023Article
- The role of digital technology in surgical home hospital programs.NPJ digital medicine · 2023Review
- Home Oxygen and Monitoring for COVID-19 Patients: A Multidisciplinary Team Approach.Journal of community hospital internal medicine perspectives · 2023Article
- International Collaboration to Develop a Remote Monitoring Web App for COVID-19 Patients in Armenia: Design and Development With Agile Methodology.JMIR human factors · 2022Article
- Patient and clinician perspectives of a remote monitoring program for COVID-19 and lessons for future programs.Research square · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe Southern California region of Kaiser Permanente developed a COVID-19 Home Monitoring program as an alternative to hospital admission to decrease hospital bed days and mitigate the adverse effects of a surge. To date, more than 15,000 patients have been enrolled and approximately 10% of enrolled patients have been escalated to hospital care for timely treatment. Our objective is to describe our COVID-19 Home Monitoring program and present early results.
methodsWe conducted an observational retrospective study of all patients enrolled in the COVID-19 Home Monitoring program between April 13, 2020 through February 12, 2021. Data analysis conducted includes patient demographics, enrollment, entry points, length of stay, mortality, additional treatment, utilization, adherence, satisfaction, and alert triggers.
resultsA total of 12,461 of 13,055 patients (95.5%) recovered and completed the program, 1387 patients (10.6%) were admitted to the hospital, and 20 patients (0.2%) died while they were being monitored at home. The mortality rate at 30 days from enrollment was 1.6%. Hospital length of stay for ambulatory patients receiving oxygen only was 5.4 days compared to 3.1 days for those ambulatory patients receiving oxygen, dexamethasone, and remdesivir.
conclusionCOVID-19 home monitoring appears to be safe and effective. Initial data suggest it can serve as an alternative to hospitalization, decreasing hospital length of stay when patients receive therapies in the ambulatory setting otherwise reserved for the hospital. Initial results of this Home Monitoring program appear to be promising, and a longer term prospective study is warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.